SOLANA BEACH, CALIFORNIA / ACCESS Newswire / August 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to ...
Joseph Michael Burnett, CEO, described 2025 as the start of ClearPoint Neuro’s “third phase,” called Fast. Forward., emphasizing an expanded commitment to cell and gene therapy, workflow ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback